# Tenaya Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 7, 2025

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-07
- Accepted by EDGAR: Mar 7, 2025, 20:22 ET
- Period: not reported
- Accession: 0000919574-25-001872
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000091957425001872/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000091957425001872/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000091957425001872/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000919574-25-001872. Last ingested by Listed: Nov 4, 2026, 17:31 ET. No prices; not investment advice.